glucagon has been researched along with pirenzepine in 9 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (pirenzepine) | Trials (pirenzepine) | Recent Studies (post-2010) (pirenzepine) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 3,812 | 587 | 140 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianconi, L; Capretti, L; Coiro, V; Davoli, C; Fagnoni, F; Gardini, E; Maffei, ML; Passeri, M; Speroni, G; Volpi, R | 1 |
| Atiea, JA; Creagh, F; Owens, DR; Page, M; Peters, JR; Scanlon, MF | 1 |
| Butturini, U; Camellini, L; Chiodera, P; Coiro, V; d'Amato, L; Pignatti, D; Rossi, G; Volpi, R | 1 |
| Giordano, G; Pasquali, C; Ragazzi, E; Scandellari, C; Valentini, P; Zaccaria, M; Zeviani, M | 1 |
| Adrian, TE; Baron, JH; Bloom, SR; El-Sabbagh, HN; Prinz, RA; Welbourn, RB | 1 |
| Delitala, G; Frulio, T; Maioli, M; Pacifico, A | 1 |
| Hanai, H; Kajimura, M; Kaneko, E; Kodaira, M; Lin, S; Takeuchi, K | 1 |
| Gil, MJ; Goñi, F; Goñi, MJ; Moncada, E; Monreal, M; Salvador, J; Sopena, M | 1 |
| Joye, F; Marion, F; Michoux, I; Orrillard, M; Parisot, R | 1 |
2 trial(s) available for glucagon and pirenzepine
| Article | Year |
|---|---|
The effect of pirenzepine on meal-stimulated gastrointestinal hormones.
Topics: Adult; Benzodiazepinones; Eating; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptides; Humans; Insulin; Neurotensin; Pancreatic Polypeptide; Piperazines; Pirenzepine; Somatostatin; Vasoactive Intestinal Peptide | 1980 |
Effects of cholinergic blockade on nocturnal thyrotropin and growth hormone (GH) secretion in type I diabetes mellitus: further evidence supporting somatostatin's involvement in GH suppression.
Topics: Administration, Oral; Adult; Blood Glucose; Circadian Rhythm; Cohort Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Glucagon; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hydrocortisone; Insulin-Like Growth Factor I; Male; Muscarinic Antagonists; Pirenzepine; Somatostatin; Thyrotropin | 1997 |
7 other study(ies) available for glucagon and pirenzepine
| Article | Year |
|---|---|
Reduced sensitivity to pirenzepine-induced blockade of growth hormone responses to arginine, exercise, and growth hormone-releasing hormone in type I diabetic subjects.
Topics: Adolescent; Adult; Arginine; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Exercise; Glucagon; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Kinetics; Muscarinic Antagonists; Pirenzepine; Receptors, Muscarinic | 1990 |
Early morning hyperglycemia in insulin-dependent diabetes: acute and sustained effects of cholinergic blockade.
Topics: Adult; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 1; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hyperglycemia; Insulin; Male; Parasympatholytics; Pirenzepine | 1989 |
Muscarinic cholinergic modulation of insulin response to an intravenous glucose tolerance test in normal man.
Topics: Adult; Benzodiazepinones; Blood Glucose; Female; Glucagon; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Male; Pirenzepine; Receptors, Muscarinic | 1986 |
Effects of pirenzepine on plasma insulin, glucagon and pancreatic polypeptide levels in normal man.
Topics: Adult; Arginine; Benzodiazepinones; Blood Glucose; Glucagon; Glucose Tolerance Test; Humans; Insulin; Pancreatic Polypeptide; Pirenzepine; Radioimmunoassay; Time Factors | 1985 |
Participation of cholinergic muscarinic receptors in glucagon- and arginine-mediated growth hormone secretion in man.
Topics: Adult; Arginine; Benzodiazepinones; Glucagon; Growth Hormone; Humans; Male; Parasympatholytics; Pirenzepine; Prolactin; Receptors, Cholinergic; Receptors, Muscarinic | 1982 |
Expression of muscarinic receptor subtypes in rat gastric smooth muscle: effect of M3 selective antagonist on gastric motility and emptying.
Topics: Animals; Atropine; Butylscopolammonium Bromide; Dioxoles; Gastric Emptying; Gastrointestinal Motility; Glucagon; Male; Muscarinic Antagonists; Muscle, Smooth; Piperidines; Pirenzepine; Polymerase Chain Reaction; Rats; Receptors, Muscarinic; Stomach | 1997 |
[Severe intoxication probably from olanzapine (Zyprexa). Beneficial effect of glucagon].
Topics: Adult; Alprazolam; Antipsychotic Agents; Benzodiazepines; Bradycardia; Carbamazepine; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Gastrointestinal Agents; Glucagon; Humans; Hypothermia; Infusions, Intravenous; Male; Methotrimeprazine; Olanzapine; Pirenzepine; Schizophrenia; Shock | 1999 |